Close Menu

NEW YORK (360Dx) – Abbott's Alere business, along with Roche, Becton Dickinson, and Danaher's Cepheid each received US Food and Drug Administration clearances for tests in January, according to the FDA's website.

Alere, acquired by Abbott in October 2017, received clearances for four tests.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.